Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.5M
-
Number of holders
-
171
-
Total 13F shares, excl. options
-
73.8M
-
Shares change
-
+370K
-
Total reported value, excl. options
-
$3.12B
-
Value change
-
+$4.07M
-
Put/Call ratio
-
0.52
-
Number of buys
-
95
-
Number of sells
-
-83
-
Price
-
$42.27
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q2 2021
219 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q2 2021.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 171 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.8M shares
of 79.5M outstanding shares and own 92.81% of the company stock.
Largest 10 shareholders include FMR LLC (10.6M shares), WELLINGTON MANAGEMENT GROUP LLP (8.73M shares), VANGUARD GROUP INC (6.73M shares), BlackRock Inc. (6.52M shares), FRANKLIN RESOURCES INC (5.79M shares), RTW INVESTMENTS, LP (5.29M shares), JANUS HENDERSON GROUP PLC (3.5M shares), STATE STREET CORP (2.38M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.11M shares), and ARMISTICE CAPITAL, LLC (2.09M shares).
This table shows the top 171 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.